Relationship Between Prolonged Intraocular Inflammation and Macular Edema After Cataract Surgery

被引:11
|
作者
Aaronson, Alexander [1 ,2 ]
Taipale, Claudia [1 ,2 ]
Achiron, Asaf [3 ,4 ,5 ]
Aaltonen, Vesa [6 ,7 ]
Grzybowski, Andrzej [8 ,9 ]
Tuuminen, Raimo [1 ,10 ]
机构
[1] Univ Helsinki, Helsinki Retina Res Grp, Helsinki, Finland
[2] Helsinki Univ Hosp, Dept Ophthalmol, Helsinki, Finland
[3] Edith Wolfson Med Ctr, Dept Ophthalmol, Holon, Israel
[4] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel
[5] Bristol Eye Hosp, Dept Ophthalmol, Bristol, Avon, England
[6] Turku Univ Hosp, Dept Ophthalmol, Turku, Finland
[7] Univ Turku, Dept Ophthalmol, Turku, Finland
[8] Univ Warmia & Mazury, Dept Ophthalmol, Olsztyn, Poland
[9] Fdn Ophthalmol Dev, Inst Res Ophthalmol, Poznan, Poland
[10] Kymenlaakso Cent Hosp, Dept Ophthalmol, Kotkantie 41, FI-48210 Kotka, Finland
来源
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY | 2021年 / 10卷 / 07期
关键词
aqueous flare; cataract surgery; intraocular inflammation; macular edema; perioperative treatment; pseudophakic cystoid macular edema; AQUEOUS FLARE INTENSITY; ANTERIOR-CHAMBER FLARE; CELL METER; CYTOKINES; PHACOEMULSIFICATION; PILOCARPINE; TROPICAMIDE; PREVENTION;
D O I
10.1167/tvst.10.7.15
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To assess whether aqueous flare is related to an increased risk of pseudophakic cystoid macular edema (PCME) following uneventful cataract surgery in nondiabetic and diabetic patients. Methods: A post hoc analysis of five consecutive randomized clinical trials in the Department of Ophthalmology, Kymenlaakso Central Hospital, Finland. Aqueous flare levels were recorded in 448 eyes of 448 patients before surgery, and after the course of topical anti-inflammatory treatment 28 days and three months after cataract surgery. Results: Aqueous flare increase of <50%, >= 50%, >= 100%, and >= 200% associated in central subfield macular thickness (CSMT) increase across the groups at 28 days and three months after surgery. Increase of aqueous flare >= 100% compared to those with <100% was associated with increased CSMT (P = 0.022 at 28 days, and P = 0.027 at three months). At three months, macular thickening (at least 10% CSMT increase) was observed in 12.7% compared to 4.6% of eyes when using a cutoff value of 100% increase in aqueous flare (P = 0.033). Although diabetic patients presented higher aqueous flare levels at baseline compared to nondiabetic patients (12.9 +/- 11.8 vs. 9.8 +/- 8.2 photon units/ms P < 0.001), the postoperative levels illustrated a similar profile in aqueous flare increase between the two groups. Conclusions: At 28 days, aqueous flare increase was associated with macular thickening. A 100% cutoff value could potentially be used when studying anti-inflammatory efficacy of different treatment protocols. Flare values exceeding this cutoff value could be considered as an indication for extending anti-inflammatory therapy. Translational relevance: A 100% increase in aqueous flare at 28 days after cataract surgery from baseline predicted macular thickening up to three months postoperatively. Identifying a correlation between increased aqueous flare levels and pseudophakic cystoid macular edema may allow recognition of the most vulnerable patients, development of prophylactic treatment strategies and reduction of the number and severity of postoperative complications.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Prevention of macular edema after cataract surgery
    Wielders, Laura H. P.
    Schouten, Jan S. A. G.
    Nuijts, Rudy M. M. A.
    CURRENT OPINION IN OPHTHALMOLOGY, 2018, 29 (01) : 48 - 53
  • [2] MACULAR EDEMA AFTER CATARACT SURGERY IN EYES WITH PREOPERATIVE RETINAL VEIN OCCLUSION
    Cho, Han Joo
    Hwang, Hyun Ji
    Kim, Hyoung Seok
    Lee, Dong Won
    Kim, Chul Gu
    Kim, Byoung Yeop
    Kim, Jong Woo
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 (06): : 1180 - 1186
  • [3] The Effect of Latanaprost on Intraocular Inflammation and Macular Edema
    Razeghinejad, M. Reza
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2019, 27 (02) : 181 - 188
  • [4] Macular edema after cataract surgery in eyes with and without pseudoexfoliation syndrome
    Ilveskoski, Lotta
    Taipale, Claudia
    Holmstrom, Emil J.
    Tuuminen, Raimo
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2019, 29 (05) : 504 - 509
  • [5] Measuring Anterior Chamber Inflammation After Cataract Surgery: A Review of the Literature Focusing on the Correlation with Cystoid Macular Edema
    De Maria, Michele
    Iannetta, Danilo
    Cimino, Luca
    Coassin, Marco
    Fontana, Luigi
    CLINICAL OPHTHALMOLOGY, 2020, 14 : 41 - 52
  • [6] Macular edema after cataract surgery in diabetic eyes evaluated by optical coherence tomography
    Chen, Xiao-Yong
    Song, Wen-Jun
    Cai, Hong-Yuan
    Zhao, Lin
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2016, 9 (01) : 81 - 85
  • [7] Incidence and Remission of Post-Surgical Cystoid Macular Edema Following Cataract Surgery in Eyes With Intraocular Inflammation
    Gangaputra, Sapna
    Newcomb, Craig
    Ying, Gui-Shuang
    Groth, Sylvia
    Fitzgerald, Tonetta D.
    Artornsombudh, Pichaporn
    Kothari, Srishti
    Pujari, Siddharth S.
    Jabs, Douglas A.
    Levy-Clarke, Grace A.
    Nussenblatt, Robert B.
    Rosenbaum, James T.
    Sen, H. Nida
    Suhler, Eric B.
    Thorne, Jennifer E.
    Bhatt, Nirali P.
    Foster, C. Stephen
    Dreger, Kurt A.
    Buchanich, Jeanine M.
    Kempen, John H.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2024, 267 : 182 - 191
  • [8] Prevalence of Cystoid Macular Edema After Cataract Surgery in Eyes with Previous Macular Surgery
    Padidam, Sneha
    Skopis, George
    Lai, Michael M.
    CLINICAL OPHTHALMOLOGY, 2022, 16 : 423 - 427
  • [9] Intravitreal triamcinolone for intraocular inflammation and associated macular edema
    Couch, Steven M.
    Bakri, Sophie J.
    CLINICAL OPHTHALMOLOGY, 2009, 3 : 41 - 47
  • [10] Cystoid macular edema after low-energy femtosecond-assisted cataract surgery
    Latz, Catharina
    Licht, Annika
    Bayati, Peyman
    Taya, Kazem
    Mirshahi, Alireza
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024, : 829 - 835